The trajectory of Viagra, originally marketed by copyright, presents a intricate case study for stakeholders considering the healthcare sector. While its early success and generation of billions in revenue , the intellectual property lapse has opened the door for generic medications, significantly eroding earnings prospects . This shift raises doub